EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 41 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $189,000 | – | 42,787 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 896,600 | $2,412,000 | 0.36% |
| Camber Capital Management LP | 1,847,500 | $4,970,000 | 0.29% |
| Broadfin Capital, LLC | 1,079,543 | $2,904,000 | 0.28% |
| BAILARD, INC. | 604,500 | $1,626,000 | 0.23% |
| SOUTHPORT MANAGEMENT, L.L.C. | 50,000 | $135,000 | 0.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,223,922 | $5,982,000 | 0.06% |
| HIGHLAND CAPITAL MANAGEMENT LP | 190,033 | $512,000 | 0.02% |
| Abingworth LLP | 7,896 | $21,000 | 0.02% |
| JENNISON ASSOCIATES LLC | 2,613,159 | $7,029,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 772,007 | $2,077,000 | 0.01% |